Project Details
Description
Methanobactins (Mbns) are small copper-binding peptidic
natural products first identified in methanotrophic bacteria
(Fig. 1), microorganisms that utilize methane gas a carbon
source.1,2 Operons resembling the putative Mbn biosynthesis
operon have recently been identified in a range of proteobacterial
species via genome mining.3 I hypothesize that these operons
encode the biosynthetic machinery needed to produce
Mbn-like peptidic natural products, and that differing peptidic
backbones and post-translational modifications will confer on
these products a range of copper affinities and specificities.
This expanded set of Mbns will provide drug candidates for
diseases related to copper overabundance.
Status | Finished |
---|---|
Effective start/end date | 7/1/14 → 6/30/16 |
Funding
- American Heart Association Midwest Affiliate (14PRE20460104)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.